Liquidia stock jumps after $148.3 million YUTREPIA sales update — what LQDA investors watch next week
Liquidia shares rose 12.9% to $35.86 Friday after the company reported preliminary 2025 YUTREPIA sales of $148.3 million, with $90.1 million in Q4. The company ended 2025 with $190.7 million in cash and over $30 million in positive Q4 cash flow. CEO Roger Jeffs will present at the J.P. Morgan Healthcare Conference on Jan. 14. Audited results are expected in February.